stockrow
Friday 6 November 2026
Export SNWV’s income statement to Excel — free account
Sanuwave Health Inc.
SNWV Healthcare Medical Devices
Sanuwave Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.1 million, up 35.0% from fiscal 2024.
- Revenue
- −3.13%
- EPS
- −224.2%
- Free cash flow
- +86.8%
- Total debt
- −28.4%
Quarter to June 2026, against a year earlier
2.20
0.05
−2.22%
Follow SNWV
Alert me
Sanuwave Health Inc. (SNWV) P/E ratio
As of 5 November 2026, Sanuwave Health Inc. (SNWV) trades at a P/E ratio of 1.3×. Over the past ten years it has ranged from 0.0× (December 2025) to 112× (December 2024); the current reading is higher than 49% of that period. That is below the Medical Devices industry median of 25.6× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 20.8× | — |
| FY2024 | 0.0× | — |
| FY2023 | 62.0× | 0.00% |
| FY2022 | 62.0× | 0.00% |
| FY2021 | 62.0× | 0.00% |
| FY2020 | 62.0× | 0.00% |
| FY2019 | 62.0× | 0.00% |
| FY2018 | 62.0× | 0.00% |
| FY2017 | 62.0× | 0.00% |
| FY2016 | 62.0× | 0.00% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 5.6× | (37.47%) |
| Mar 2026 | 9.0× | (56.81%) |
| Dec 2025 | 20.8× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 112×
Ten-year median
2.4×
Current reading's percentile
49
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MDAI Spectral AI, Inc. compare | n/m |
| TELA TELA Bio, Inc. compare | n/m |
| CVRX CVRx, Inc. compare | n/m |
| SRTS Sensus Healthcare, Inc. compare | n/m |
| MYO Myomo, Inc. compare | n/m |
| COCH Envoy Medical, Inc. compare | n/m |
| NSPR InspireMD, Inc. compare | n/m |
| XTNT Xtant Medical Holdings, Inc. compare | n/m |
| SNWV Sanuwave Health Inc. | 1.3× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)